Elixinol Wellness (AU:EXL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Elixinol Wellness Limited has announced the issuance of 1,641,652 fully paid ordinary shares following the exercise of vested Director Fee Rights. This strategic move aligns with the company’s commitment to expanding its presence in the hemp industry, where it continues to innovate and sell a range of plant-derived products. Investors may find interest in the company’s vertically integrated operations and diverse product offerings across human and pet wellness, nutrition, and superfood ingredients.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.
